POPULARITY
Friday, February 28, 2025 - Week 9 Hope vs. Despair? Despair: NIH Cuts NBC https://www.nbcnews.com/science/science-news/trumps-nih-budget-cuts-threaten-research-stirring-panic-rcna191744 NYT https://www.nytimes.com/2025/02/25/briefing/president-trump-vs-medical-research.html?unlocked_article_code=1.0U4.-7WW.F3yrk2tjpLJe&smid=url-share FDA Staffing Cuts https://www.biopharmadive.com/news/fda-layoffs-trump-doge-hhs-cuts-impact/740499/ Medicaid Cuts https://www.disabilityscoop.com/2025/02/27/house-vote-tees-up-billions-in-cuts-to-medicaid-disability-services/31321/ https://www.politico.com/news/2025/02/27/republicans-medicaid-expansion-budget-00206612 President who doesn't care https://time.com/7002003/donald-trump-disabled-americans-all-in-the-family/ DOGE head who also doesn't care https://www.usatoday.com/story/life/health-wellness/2025/02/25/elon-musk-donald-trump-disabled-people/80112602007/ Hope: Pipeline https://curesyngap1.org/syngap1-related-disorder-therapeutic-pipeline/ Community https://curesyngap1.org/team/ Global: https://syngapglobal.net/ ICD-10 Code https://www.rareepilepsynetwork.org/about-icd-codes Disability is Political Take it or Advocate? Taking it does not work. Advocate: SRF https://curesyngap1.org/srf-legislative-advocacy-efforts-for-syngap1/ ELF https://everylifefoundation.org/ Research America https://www.researchamerica.org/marys-letters/research-advocates-unite-in-force/ Alliance for a Stronger FDA https://www.strengthenfda.org/ Modern Medicaid Alliance https://modernmedicaid.org/about-the-alliance/ Annie Kennedy's comments at the ELF Capitol Briefing: https://www.youtube.com/live/F6kfKsYCQYU?si=ihWOl7Lda7Steg3p&t=3391 Responsibility to those who cannot or will not be here. 10% of Americans. 10k diseases, all chronic. Childhood. Do not have FDA approved treatments, no cures. Staggering Financial Costs aka Toxicities. Efforts to date have allowed for interventions that may still matter. We have invested so much. Episode 163 of #Syngap10 #Advocate #PatientAdvocacy #UnmetNeed #SYNGAP1
Several major federal cases against President-elect Donald Trump have been dropped or dismissed. The US attorney overseeing Sean “Diddy” Combs and Eric Adams cases plans to step down. National abortion policy may not be as simple as the incoming Trump administration hopes. We'll tell you how vaping affects vascular health. Plus, where is America's nuclear waste? Learn more about your ad choices. Visit podcastchoices.com/adchoices
First – Eugene Mulero -- senior congressional reporter for Transport Topics -- discusses federal oversight of the freight rail industry in the wake of that toxic train derailment in Northeast Ohio Then, Josh Golin from the child advocacy group Fairplay -- discusses bipartisan efforts to protect kids' safety online. Plus, Research America president and CEO Mary Woolley discusses federal investments for medical, science, and technology research. Learn more about your ad choices. Visit megaphone.fm/adchoices
In this short interview with Philip Stoten, Director and Head of R&D at Koh Young Research America (KYRA), Dr. Brian Kang, shares some insight into the application of AI in inspection and electronic manufacturing. Dr. Kang explains the importance of dataset selection and data quality in building machine learning and AI strategies.EMSNOW & SCOOP at APEX 2023 was sponsored by Koh Young America (https://www.kohyoung.com), Aegis Software (https://www.aiscorp.com/), Panasonic Connect (https://connect.panasonic.com/en/) and Cogiscan (https://cogiscan.com/).Like every episode of EMS@C-Level, this one was sponsored by global inspection leader Koh Young (https://www.kohyoung.com) and Adaptable Automation Specialist Launchpad.build (https://launchpad.build).You can see video versions of all of the EMS@C-Level pods on our YouTube playlist.
We welcome one of the nation's most respected health and health policy thought leaders to Raise the Line on this episode. Susan Dentzer's remarkable career includes many years of reporting on healthcare for major national news outlets, being a senior policy adviser to the Robert Wood Johnson Foundation and serving as a board leader in medical education and health system delivery, just to name a few of her contributions. Earlier this year, Ms. Dentzer was appointed president and CEO of America's Physician Groups, an organization representing more than 350 physician groups providing coordinated, value-based healthcare for more than ninety million patients nationwide. She's also currently board chair of Research America, which advocates on behalf of biomedical and health-related research and innovation. Tune in to this elucidating discussion with host Shiv Gaglani that delves into what the pandemic revealed about value-based care and virtual care; what is helping to lessen clinician burnout; surprising views among medical students on the use of tech in healthcare; what is at the root of the public's mistrust of science, and much more. “The reality of healthcare is very complicated. What I would make a plea for is that we all try to engage in developing a greater understanding of the issues, as opposed to seeing them through a narrow lens.”Mentioned in this episode: https://www.apg.org/https://www.researchamerica.org/
The Biden administration has said COVID-19 vaccine boosters may be available to eligible groups a week from now. But that timing is uncertain and scientific advisory committees still need to meet in the next several days. Lisa Desjardins spoke with CDC Director Dr. Rochelle Walensky about the status of boosters and the spread of the virus as part of a special forum hosted by Research America. PBS NewsHour is supported by - https://www.pbs.org/newshour/about/funders
The Biden administration has said COVID-19 vaccine boosters may be available to eligible groups a week from now. But that timing is uncertain and scientific advisory committees still need to meet in the next several days. Lisa Desjardins spoke with CDC Director Dr. Rochelle Walensky about the status of boosters and the spread of the virus as part of a special forum hosted by Research America. PBS NewsHour is supported by - https://www.pbs.org/newshour/about/funders
On this week's episode of the Accelerate Health podcast, Rob Havasy invites Alex Gao, Founder and Head of the Digital Health Lab for Samsung Research America to talk with him about how consumer device companies are forging a path of true and effective innovation in the healthcare space. Alex discussed the advances Samsung has made branching into the healthcare industry and focusing on technology that champions for consumer empowered health.
Stat: 40%: 4 in 10 Americans identify with a race other than White. Story: In our first episode on race and research, we explore the diverse story of America. William Frey, senior fellow at the Brookings Institution and an internationally regarded demographer, highlights the latest census findings and what they say about the nation today. And we examine what these changes mean for society—and the evolving national conversation about race—with the Pew Research Center’s director of race and ethnicity research, Mark Hugo Lopez.
We’d love to hear from you (feedback@breakingbadscience.com)Look us up on social media Facebook: https://www.facebook.com/groups/385282925919540Instagram: https://www.instagram.com/breakingbadsciencepodcast/Website: http://www.breakingbadscience.com/Patreon: https://www.patreon.com/breakingbadscienceStem cells are a mysterious cellular construct with some pretty unique properties. Properties which have led to intense discussions about life, aging, cancer, the nature of disease itself, and even religion. But what are they? Why was the discovery of these cells so important? Why are they so controversial and how has that controversy affected research in the last few decades? Join hosts Shanti and Danny as we discuss stem cells, the confusion surrounding them, and why the controversy is not only important but necessary in this episode of Breaking Bad Science. ReferencesPlatt, A.; A Brief History of U.S. Stem Cell Policy. Research America. 2020. https://www.researchamerica.org/advocacy-action/issues-researchamerica-advocates/stem-cell-research/brief-history-us-stem-cellHwang, N., et. al.; Controlled Differentiation of Stem Cells. Advanced Drug Delivery Reviews. 11-Oct-2007. 60:2 (199 - 214). Doi: https://doi.org/10.1016/j.addr.2007.08.036Robinton, D., Daley, G.; The Promise of Induced Pluripotent Stem Cells in Research and Therapy. Nature. 18-Jan-2012. 481 (295 - 305). Doi: https://doi.org/10.1038/nature10761Chin, M., et. al.; Induced Pluripotent Stem Cells and Embryonic Stem Cells are Distinguished by Gene Expression Signatures. Cell - Stem Cell. 2-Jul-2009. 5:1 (111 - 123). Doi: https://doi.org/10.1016/j.stem.2009.06.008Biehl, J., Russell, B.; Introduction to Stem Cell Therapy. Journal of Cardiovascular Nursing. Mar/Apr-2009. 24:2 (98 - 105). Doi: https://doi.org/10.1097/JCN.0b013e318197a6a5Ayala, F.; Cloning Humans? Biological, Ethical, and Social Considerations. PNAS. 21-Jul-2015. 112:29 (8879 - 8886). Doi: https://doi.org/10.1073/pnas.1501798112Hernandez, D.; 500 Years Later, da Vinci’s Mechanical Lion is Brought to Life. Popular Mechanic. 19-Sep-2019. https://www.popularmechanics.com/technology/a29020685/leonardo-da-vinci-mechanical-lion-display/Ayob, A., Ramasamy, T.; Cancer Stem Cells as Key Drivers of Tumour Progression. Journal of Biomedical Science. 06-Mar-2018. 25:20. Doi: https://doi.org/10.1186/s12929-018-0426-4Kim, K.S.; Converting Human Skin Cells to Neurons: A New Tool to Study and Treat Brain Disorders? Cell - Stem Cell. 2-Sep-2011. 9:3 (179 - 181). Doi: https://doi.org/10.1016/j.stem.2011.08.004Support the show (https://www.patreon.com/breakingbadscience?fan_landing=true)
Rex Repass President, Research America, A DotCom Magazine Exclusive Zoom Interview About Rex Repass Rex is the man behind the story, a bold leader and entrepreneur. He is highly experienced helping organizations drive profitable growth and enhance corporate reputations. As President he challenges the Research America team to move forward, innovate, and to think differently using his years of experience as a guiding light. Rex offers this same level of vision with clients, illuminating the path forward and inspiring courage and confidence. Rex can also hold his own against Wikipedia on any sports statistics and presidential history. Go ahead, try to stump him. Rex has a Master of Science degree in Communications, with an emphasis in public opinion and advertising research methods. He serves on the University of Tennessee's College of Communications & Information Board of Visitors. --- This episode is sponsored by · Anchor: The easiest way to make a podcast. https://anchor.fm/app
Benjamin Nichols of Radio Free Hillsdale discusses the history of guns in America and why your right to a firearm extends past government authority. He also breaks down the truth about misleading firearm statistic and how Joe Biden plans to infringe on your right to self-protection.
Welcome back to Intellicast! On today’s episode, Brian Lamar and Producer Brian are joined by EMI’s Mary Draper. If you a frequent listener, you’ll remember Mary from last season’s episode that kicked off the obsession with Publix. Mary gives us an update from her recent trip to visit not 1, but 3 different Publix over the holidays. After the great update, we dive into the latest marketing research news. In the first story, we discuss the Confirmit and FocusVision merger, and the potential impact on the survey programming space. In our next story, they discuss Research America’s purchase of Segmedica and how it looks like they plan to grow in the pharmaceutical industry. In the second the last story, Brian, Mary, and Producer Brian discuss Samplechain hiring Matt Gershner away from Greenbook to be their new Chief Strategy & Revenue Officer. After the news, Mary and Brian talk about best practices for managing a sample provider network. Mary discusses the processes she has put into place as EMI’s Network Quality Officer, as well as how she evaluated potential partners, and what causes partners to be removed. Mary is super thorough – you’ll be a network management expert after this episode. Thanks for listening! You can learn more about EMI’s DIY sample platform, CONNECTOR, and request a demo by visiting our website at www.emi-rs.com/connector/. Missed one of our webinars or want to get some of our whitepapers and reports? You can find it all on our Resources page on our website here: https://emi-rs.com/resources/ Got a suggestion or feedback? Reach out to us at Intellicast@emi-rs.com, or on Twitter at @Intellicast1, or leave us a voicemail on our call-in line at 513-401-5463.
Today we have a discussion of COVID-19 vaccines, and vaccination with Dr. Peter Hotez.Peter Hotez MD Ph.D. is professor of pediatrics and molecular virology at Baylor College of Medicine, where he is also co-director of the Texas Children’s Center for Vaccine Development and Endowed Chair in Tropical Pediatrics. He is a vaccine scientist who led the development of vaccines to prevent and treat neglected tropical diseases and coronavirus infections. A new Texas Children’s COVID19 vaccine is being accelerated in India now undergoing clinical testing.Prof. Hotez obtained his undergraduate degree from Yale University and his MD and Ph.D. from Weil Cornell Medical College and Rockefeller University. He is the author of more than 550 scientific articles indexed on PubMed, and 4 single-author books. He is an elected member of the National Academy of Medicine and American Academy of Arts & Sciences, and has been honored by PAHO/WHO, Research America, B’nai Brith, American Society of Tropical Medicine & Hygiene, and other organizations. He appears frequently on major news outlets promoting global health, and vaccines and immunizations, countering antivaccine and Antiscience movements.
Dotan is a computer vision and image processing professional with over 20 years of experience transforming hard problems into usable solutions. He has lived and worked with Israeli, US, Japanese and Swiss teams, and is a researcher in Samsung Research America. His current passion is leading a team that develops computer vision, graphics, and algorithms for AR and VR.
Rex Repass, a native West Virginian, is President of Research America Inc. In this podcast, Rex will tell us about his life-long interest in the effects of media and marketing on consumer decision making – from the cars they drive to the candidates they support. He has an interesting story to share from his first market research venture in the early 1980s to now leading a Top 50 research firm in the U.S. ----more---- About Matthew's guest: Rex Repass is President of Research America Inc. The company has 250 employees in the U.S., with locations in Philadelphia, metro New York, Cincinnati, Detroit, Orlando, and Sacramento. The Research America teams have designed and led market research and consumer insights projects for some of the leading corporations in the world including Walgreens, Pfizer, Honda, Facebook, and Hilton Hotels. In addition, over the years Rex and his teams have conducted public opinion and user experience research for more than 40 newspapers in the U.S. and Canada, and the Reuters News Agency. Rex is a life-long entrepreneur. He has been an owner in three market research firms during his career. Companies he has led have been named to Inc. magazine’s annual list of the fastest-growing, privately-held companies in America multiple times. In 2020, Research America was also named one of the Top 50 market research firms in the U.S. based on annual revenue by the GreenBook Research Industry Trends Report (GRIT). A native of Charleston, West Virginia Rex remains close to his roots. For many years he has directed The West Virginia Poll™ sponsored by the MetroNews Radio Network. Rex received an undergraduate degree from Marshall University and in 2017 was named a Distinguished Alumnus of Marshall’s College of Arts and Media. He is also a former Marshall athlete and was a member of Coach Jack Lengyel’s Young Thundering Herd football team in the early 1970s. In 1977, Rex received a Master of Science degree in Communications from the University of Tennessee, with an emphasis in public opinion and advertising research methods. He currently serves as Vice-Chair of UT’s College of Communications & Information Sciences Board of Visitors. Rex is based in Research America’s Cincinnati office and he and his wife Theresa are the parents of four adult daughters. WVU Marketing Communications Today is hosted by Matthew Cummings from West Virginia University which is a program on the Funnel Radio Channel.
Physician economist Anupam B. Jena advances the understanding of what works and what does not work in health care by using “natural experiments” and big data. He studies phenomena such as the economics of physician behavior and the physician workforce, health care productivity, and the economics of medical innovation. Bapu is the Ruth L. Newhouse Associate Professor of Health Care Policy at Harvard Medical School, an internist at Massachusetts General Hospital, and a Faculty Research Fellow at the National Bureau of Economic Research. He is the 2007 recipient of the Eugene Garfield Award by Research America for his work demonstrating the economic value of medical innovation in HIV/AIDS. In 2013, he was the first social scientist to win the NIH Director's Early Independence Award. His research and editorials have been featured in the New York Times, Washington Post, Wall Street Journal, Freakonomics, and NPR. He is also co-host of the podcast, Tradeoffs, which aims to make sense of the complicated, costly, and often counterintuitive world of health care. He spoke at TEDMED 2020 in Boston. Kali D Cyrus holds a BA in Psychology from Stanford University, an MPH in health policy & management from Emory University and an MD from the University of Illinois at Chicago. She completed her adult psychiatry residency training and served as a public psychiatry fellow at the Yale School of Medicine. Kali is currently an assistant professor in the Department of Psychiatry of Johns Hopkins School of Medicine. She worked on Capital Hill from 2017- 2018 as a health policy fellow in the Office of Senator Chris Murphy and was a Jeanne Spurlock congressional fellow. View her recent work: How Racism is Causing Black and Latinx Communities to Die of COVID-19 at Higher Rates on NowThis News
Women in AI is a biweekly podcast from RE•WORK, meeting with leading female minds in AI, Deep Learning and Machine Learning. We will speak to CEOs, CTOs, Data Scientists, Engineers, Researchers and Industry Professionals to learn about their cutting edge work and technological advancements, as well as their impact on AI for social good and diversity in the workplace.
Benjamin Nichols of Radio Free Hillsdale discussed America’s influence over the world, the Iran crisis, and how to deal with China with Callahan Stoub and Kathleen Hess, President and Treasurer of the Alexander Hamilton Society. They also talked about the effectiveness of tariffs and economic warfare.
Welcome to the MRMW NA 2019 Conference Series. Recorded live in Cincinnati, this series is bringing interviews straight to you from exhibitors and speakers at this year’s event. In this interview, host Jamin Brazil interviews Will Krieger, VP of Research America. Contact Will Online: LinkedIn WillK@ResearchAmericaInc.com Research America [00:00] Will Krieger, Research America, MRMW – He and I got to spend a few minutes together talking about how Research America is improving overall insights deliveries into their customers. Another piece of our conversation, which I actually thought was really interesting, is that M&A strategy that Rob Porter has put together with Research America to drive 16 successful acquisitions in just a five-year period of time. I can give you a hint as to what the solution is: It’s all about core values, fit, and culture. Enjoy. [00:37] My guest today is Will Krieger, Research America. Will, thanks for being on the Happy Market Research Podcast. [00:44] Thanks for having me. [00:45] So, we’re live today at MRMW in Cincinnati, Ohio. Have you been to this show before? [00:51] I have. First time was last year. [00:53] OK, got it. And are you from... I know Research America has an office here, right? [00:57] We do. Yeah, we’re in Blue Ash. If you know Cincinnati. So, northern Cincinnati. And I am from Cincinnati. I’ve been here, born and raised in Cincinnati, which is not at all uncommon in the Cincinnati area. [01:10] Yeah, I had an employee from here. So, my previous business partner, Jayme Plunkett and I, hired out of his graduating class out of Stanford. And one of them, Alex (I forget his last name now), but was native Cincinnati. And one of the things I found out about the community is, it’s kind of like if you’re born here, you stay here. [01:31] Exactly, and I’ve stayed here. [01:33] Yeah, that’s right. That’s great, though. [01:36] Family’s a big part of that. [01:36] It is. [01:38] Right. You’ve got the whole family here. It’s hard to break away from that. [01:41] It’s about those core values, I think, too, right? You have like the similar world view on what’s important and that helps at a corporate level or support that at a corporate level is... If you go to a different environment, they might not think that those same values are important, and so driving you to do different behaviors that aren’t supportive. [02:00] Very true, very true. [02:02] Which is nice about Research America, thinking about that business as... I know Rob Porter, the CEO, very family-oriented individual. That’s nice to have that little consistency. [02:13] Absolutely. Every company that we’ve acquired (maybe we’ll get into that) has that same kind of set of core values, if you will: Collaboration is a big one; integrity; several others. We all have the same set of core values, which helps us mesh together as a team. [02:37] Yeah, I love that. And that’s one of the things I’ve been picking up more and more with successful companies, is that the intangible, the community that’s created inside of the organization is more important that the assets that are sold. And my these is that (and this isn’t like some Ah-ha moment that anybody’s going to have; this is well documented) is that the one piece of intellectual property that we have that keeps us differentiated in the marketplace is the relationship with the customer, right? And if you can drive that relationship internally, it’ll naturally be an extension externally. [03:12] Mh-hmm, I agree. I would add it’s the relationship with the customer and the relationship you have with one another, right? In order to do your best work, I think it’s critical to have a team that can really gel well together, come up with great ideas,
We have a jam-packed episode of Intellicast this week! In this week’s episode, the guys talk about the big announcement of Adam being named President of EMI. They also chat about what they are looking forward to this year at SampleCon in Austin. We also have Adam Dietrich join to talk about the Research Now – SSI rebrand to Dynata. In the second half of the episode, we are joined by Rex Repass, President of Research America Inc. They discuss how Rex got started in market research, what he sees as some of the trends in the industry, and what’s new at Research America Inc. To learn more about Research America Inc, visit their website at www.researchamericainc.com. You can follow Rex on Twitter at @rlrepass. To register for SampleCon, visit https://samplecon.com/ If you want to learn more about The Sample Landscape, the report Brian has been talking about, you can download a copy here: https://emi-rs.com/the-sample-landscape/
Hi, I’m Jamin Brazil and you’re listening to the Happy Market Research Podcast. Today, my guest is Robert Porter, CEO of Research America. Research America is a leading marketing research and consumer insights company, serving the likes of PWC, Little Caesar’s, and Wrangler. FIND ROBERT ONLINE: http://www.researchamericainc.com/ Linkedin: https://www.linkedin.com/in/robert-porter-1271454/#experience-section FIND US ONLINE: www.happymr.com Social Media: @happymrxp LinkedIn: https://www.linkedin.com/company/happymarketresearch/ [0:00] In today’s episode of Happy Market Research. we’re going to hear from Robert Porter, the CEO of Research America. I’m going to tell you right now this is one of the most emotionally charged episodes that we have had on Happy Market Research and, honestly, across all the podcasts I have subscribed to. So I hope that you will tune in; stay with the story. It’s got a great ending, but it’s a very interesting journey that this man has been on. [00:30] Over the last decade the market research industry has been disrupted. Our largest agencies are struggling to keep up as their customers turn to newer, faster and cheaper data sources. Now we are on the edge of yet another major market shift. Now is the time for us to reassert ourselves as the rudder of the brands we love. Thank you for tuning in to the Happy Market Research Podcast where we are charting the path for the future of market researchers and businesses. Hi, I’m Jamin Brazil, and you’re listening to the Happy Market Research Podcast. Today my guest is Robert Porter, CEO of Research America. Research America is a leading market research and consumer insights company, serving the likes of PWC, Little Caesars, and Wrangler. Robert, thanks very much for being on the Happy Market Research podcast. [01:14] Thank you for having me. [01:16] We’d like to start out with our signature question: Tell us a little bit about your parents and how that’s affected your current career. [01:21] So, interesting question. So, a little bit different than most folks. At three years old, my mother put me on a plane with my two sisters. She went to one terminal; I went to the other. So, I was sent to Philadelphia. She called her mother and said, “Hey, the kids are going there; I’m going to Spain.” And that was the last I’ve seen my mother. I’ve seen her two other times. So that’s obviously had an impact on me for sure. So not all impact that you get from your parents is always something that’s reinforcing or helpful or positive. Sometimes negative things help you as well. So, I floated around the system for a while after leaving my grandmother’s because there were three kids (two sisters) and, as the boy, which one flew out the coop. So I was gone. And I was in the system and went through different homes, went through a lot of things, both physical and emotional, and it taught me a lot. So there’s some positive as well. I was in neighborhoods that had some wealth, education. And I was able to learn from different homes that I lived in from different parenting and different techniques how people succeeded. There’s really nothing that I could say that’s more motivation than having a parent tell you or a parent-type person, “Hey, you’re not going to amount to anything. You’re not going to be a good parent. You should just be a good gym teacher. That’s all you can do.” There’s nothing that gives you more motivation than something like that. So the motivation that I got from growing up really came from those types of things, and how to overcome that, and how to be a better person than other people saw you. So that’s what I had. [02:55] I love that – coming out of this catastrophic spot and then pivoting into the successful company that you subsequently built with Research America. Now the CEO of a large company and then starting quite literally with nothing, not even a support network. Outside of that,
Dr. Lucinda Maine's bio: Lucinda L. Maine, Ph.D., R.Ph. Executive Vice President and CEO American Association of Colleges of Pharmacy Dr. Lucinda L. Maine serves as executive vice president and CEO of the American Association of Colleges of Pharmacy. As the leading advocate for high quality pharmacy education, AACP works to develop strong academic scholars and leaders, to support excellent professional doctoral and postgraduate degree programs and build relations with key constituency groups both inside and external to the profession of pharmacy. Prior to assuming her current role in July 2002, Maine served as senior vice president for policy, planning and communications with the American Pharmacists Association (APhA). Analyzing trends in healthcare, assessing the implications for pharmacy practice and advocating appropriate recognition for all pharmacists were her top priorities at APhA. Maine is a pharmacy graduate of Auburn University and received her doctorate at the University of Minnesota. She served on the faculty at the University of Minnesota where she practiced in the field of geriatrics and was an associate dean at the Samford University School of Pharmacy. She currently serves on the Board of Directors for Research America and is an Executive Committee member of the American Foundation for Pharmaceutical Education. New media campaign for pharmacy: https://pharmacistsforhealthierlives.org/ AACP: www.aacp.org Hope to see you at ASCP's annual meeting soon too! www.ascp.com for details Nov 1-4, 2018 in National Harbor, MD! See omnystudio.com/listener for privacy information.
Peter Hotez talks about neglected tropical diseases: what are they, where are they found, and where did the term “neglected tropical disease” come from, anyway? Hotez discusses some of the strategies his and other groups are using for vaccine development, and his work as an advocate for childhood vaccines and global health. Host: Julie Wolf Subscribe (free) on iPhone, Android, RSS, or by email. You can also listen on your mobile device with the ASM Podcast app. Julie's biggest takeaways: Renaming “other diseases” - a large collection of disparate diseases such as schistosomiasis, leishmaniasis, and onchocerciasis (also called river blindness) - as “neglected tropical diseases” by Hotez and colleagues was integral to bringing attention to the diseases of the bottom billion, people that live on less than one U.S. Dollar per day. Neglected tropical diseases are often chronic and debilitating without high mortality. These diseases trap people in poverty due to their long-term effects. The NTDs are often associated with terrible stigma that can lead to additional challenges for affected populations. Neglected tropical diseases are found worldwide, in rich and poor countries. The poorest peoples living in the G20 countries (and Nigeria) now account for most of the world’s NTDs. Parasitic infections present challenges for vaccine design, but reverse vaccinology may be a useful strategy. Reverse vaccinology mines genomes to identify promising vaccine candidates in silico, which are then narrowed sequentially for those that are expressed on the bacterial surface, immunogenic, and ultimately protective against disease. This strategy has worked for Neisseria meningitidis, and Hotez is hopeful that it will produce effective vaccines for the parasitic infections he studies. The tradition of individual fields and departments, combined with the old-fashioned notion that scientists needn’t spend their time engaging with the public, has led to flatlined budgets and the rise of anti-science movements. Scientists need to engage the public to ensure the future of science and science-based policy. Featured Quotes (in order of appearance): “The concept of ‘neglected tropical diseases’ was very much born out of the Millennium Development Goals launched in the year 2000.” “Treating NTDs in rich countries “is not a resource problem; it’s an awareness problem.” “If you want to enter global health, we need as many people with a scientific background to go into business and law and international relations as we need to go into traditional scientific pathways” “Many involved in the antivaccine movement disproportionately involve either parents who are affluent or educated, or both: those who know just enough to do a google search but without the background to separate the garbage from the important stuff. And of course the anti-vaccine groups are deliberately misleading.” “Research America found that 81% of Americans can’t name a living scientist. That’s our fault. We’re so inward looking that we aren’t taking the time to do public engagement.” Links for this episode Peter Hotez at Baylor College of Medicine Peter Hotez website Millennium Development Goals published by the World Health Organization in 2000 WHO list of Neglected Tropical Diseases Forgotten People, Forgotten Diseases by Peter Hotez Blue Marble Health by Peter Hotez Public Health United episode featuring Hotez HOM Tidbit: Oncocerciasis now: 1986 British Medical Journal report Send your stories about our guests and/or your comments to jwolf@asmusa.org.
Guest: Mary Woolley, MA Host: Bruce Japsen Despite rising health-care costs paid by Americans that are routinely double the rate of inflation, money spent on research to cure what ails Americans continues to lag, says Research America chief executive officer Mary Woolley in this segment of Inside Health Care with Bruce Japsen of the Chicago Tribune.
Guest: Mary Woolley, MA Host: Bruce Japsen As political pressure builds on Republicans over the War in Iraq, will Congress finally OK a veto-proof bill to allow federal funding for embryonic stem cell research? Mary Woolley, CEO of Research America says the political climate is improving for a bill to pass and survive a Bush veto for embryonic stem cell research on Inside Health Care with Bruce Japsen of the Chicago Tribune.
Guest: Mary Woolley, MA Host: Bruce Japsen About $1 billion will be spent by candidates running for president of the United States but only $1 a year per American is spent on medical research, says Mary Woolley, CEO of Research America in her interview with Inside Health Care host Bruce Japsen of the Chicago Tribune.